The Biology of a Heart Attack: Understanding Coronary Thrombosis
At a Glance
Coronary thrombosis is a blood clot forming in a heart artery, usually after plaque rupture or erosion. The clot can reduce oxygen to heart muscle and cause a Type 1 heart attack, while Type 2 MI results from oxygen imbalance without necessarily involving a clot.
Surviving a heart event is often a dual experience: the physical relief of being in professional care and the sudden, overwhelming realization that your body’s internal systems have undergone a profound change. It is normal to feel a sense of shock or hyper-vigilance about your heart in the aftermath. Understanding the biology of what occurred—moving past the medical shorthand to the actual “plumbing” and “chemistry” involved—can be an important step in regaining a sense of control over your health.
Defining Coronary Thrombosis
At its simplest, coronary thrombosis is the formation of a blood clot (thrombus) inside one of the arteries that supplies blood to your heart muscle (coronary arteries). This is a biological event that occurs when the inner lining of the artery is disrupted, causing your blood to react as if it needs to seal a wound [1][2].
This event is the common denominator behind many of the terms you may have heard, but it is helpful to distinguish the biological process from the clinical names:
- Coronary Thrombosis: The actual biological act of a clot forming [1].
- Acute Coronary Syndrome (ACS): An “umbrella term” doctors use when they suspect blood flow to the heart is suddenly restricted. It includes heart attacks and unstable chest pain [3][4].
- Myocardial Infarction (MI): The technical name for a heart attack. “Myocardial injury” means heart muscle cells have been injured or have died, but an infarction specifically means that the injury occurred because they were deprived of oxygen [5][6].
The Two Main Paths to a Clot
Most people assume a heart attack is caused by a slow buildup of “gunk” that eventually closes the pipe. However, research shows that clots usually form suddenly because of a change in the atheroma (the medical name for a plaque or fatty deposit in the artery wall) [1][7]. There are two primary ways this happens:
1. Plaque Rupture
This is the most common cause of coronary thrombosis. In this scenario, a plaque has a very thin “cap” made of fibrous tissue [1]. Beneath this cap is a soft, unstable “necrotic core” filled with fats and inflammatory cells [8]. When this thin cap tears or “ruptures,” the highly “sticky” material inside is exposed to the bloodstream. Your blood’s clotting cells (platelets) rush to the site to seal the tear, but in doing so, they create a clot that can partially or completely block the artery [7][2].
2. Plaque Erosion
This is the second most common cause and may account for up to 40% of cases in certain populations [1]. In erosion, the plaque does not actually “burst” or rupture. Instead, the very top layer of cells lining the artery (endothelial cells) becomes damaged or dies off [9]. This leaves a “bare” patch on the artery wall. While the plaque itself remains intact, the exposed surface triggers a clot to form [7]. Interestingly, some pathology studies show erosion-related clots tend to be more platelet-rich, whereas rupture-related clots often contain more fibrin (a mesh-like protein) [9][2]. (Note: Standard hospital angiograms cannot usually identify a thin-cap plaque or the exact clot composition, but the immediate treatment is largely the same.)
Why Do Plaques Destabilize?
Researchers agree that a plaque doesn’t just “break” randomly; it undergoes a process of destabilization over time. Several factors contribute to making a plaque “vulnerable” to rupture or erosion:
- Inflammation: Specialized immune cells (macrophages) can enter the plaque and release enzymes that “digest” and weaken the protective fibrous cap [1][8].
- Microvessels: Small, leaky blood vessels can grow into the plaque itself. If these leak, they cause bleeding inside the plaque (intraplaque hemorrhage), which makes it swell and become more likely to rupture [8][10].
- Mechanical Stress: The way blood flows over the plaque (shear stress) and the presence of tiny calcium “nodules” can create physical pressure points that contribute to a break in the surface [11][12].
Understanding Your Diagnosis
When you are in the hospital, doctors use lab tests and imaging to figure out exactly what happened. They often look for a rise and fall in a protein called troponin, which is released when heart muscle is injured [5].
Modern guidelines now distinguish between two types of heart attacks based on the cause:
- Type 1 MI: This is a “classic” heart attack caused directly by plaque rupture or erosion leading to a clot [13].
- Type 2 MI: This occurs when there is an imbalance between how much oxygen the heart needs and how much it gets, but it is not necessarily caused by a sudden clot. This can be triggered by extreme stressors like a severe infection (sepsis), very high heart rates, or severe anemia [13][14][15].
Distinguishing between these helps your care team decide if you need treatments focused on “busting” or preventing clots, or if they need to focus on other underlying health stressors [6][16].
Common questions in this guide
What is coronary thrombosis, and how can it cause a heart attack?
What is the difference between plaque rupture and plaque erosion?
Does every heart attack come from a blood clot?
How do doctors determine whether I had a heart attack or another type of myocardial injury?
What should I ask my doctor after a coronary thrombosis or heart attack?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my exact discharge diagnosis (e.g., STEMI, NSTEMI, Type 1 vs Type 2 MI)?
- 2.Which specific artery was treated during my procedure?
- 3.What is my current Left Ventricular Ejection Fraction (LVEF), and how does that impact my medication plan?
- 4.Can you explain the difference between the 'myocardial injury' seen on my labs and a 'myocardial infarction' in my specific case?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (16)
- 1
Pathology of coronary atherosclerosis and thrombosis.
Otsuka F, Yasuda S, Noguchi T, Ishibashi-Ueda H
Cardiovascular diagnosis and therapy 2016; (6(4)):396-408 doi:10.21037/cdt.2016.06.01.
PMID: 27500096 - 2
Update on pathological platelet activation in coronary thrombosis.
Elia E, Montecucco F, Portincasa P, et al.
Journal of cellular physiology 2019; (234(3)):2121-2133 doi:10.1002/jcp.27575.
PMID: 30317596 - 3
Association between Inflammation and New-Onset Atrial Fibrillation in Acute Coronary Syndromes.
Băghină RM, Crișan S, Luca S, et al.
Journal of clinical medicine 2024; (13(17)) doi:10.3390/jcm13175088.
PMID: 39274304 - 4
Decision-making microRNAs (miR-124, -133a/b, -34a and -134) in patients with occluded target vessel in acute coronary syndrome.
Gacoń J, Kabłak-Ziembicka A, Stępień E, et al.
Kardiologia polska 2016; (74(3)):280-8 doi:10.5603/KP.a2015.0174.
PMID: 26365938 - 5
High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.
Sandoval Y, Apple FS, Mahler SA, et al.
Circulation 2022; (146(7)):569-581 doi:10.1161/CIRCULATIONAHA.122.059678.
PMID: 35775423 - 6
MINOCA: a heterogenous group of conditions associated with myocardial damage.
Singh T, Chapman AR, Dweck MR, et al.
Heart (British Cardiac Society) 2021; (107(18)):1458-1464 doi:10.1136/heartjnl-2020-318269.
PMID: 33568434 - 7
Pathogenesis of plaque erosion.
Riascos-Bernal DF, Quinones G, Abdelaal SA, et al.
Trends in cardiovascular medicine 2026; (36(2)):105-112 doi:10.1016/j.tcm.2025.09.004.
PMID: 40935270 - 8
Advances in Intravascular Imaging: New Insights into the Vulnerable Plaque from Imaging Studies.
Yonetsu T, Jang IK
Korean circulation journal 2018; (48(1)):1-15 doi:10.4070/kcj.2017.0182.
PMID: 29171202 - 9
Reassessing the Mechanisms of Acute Coronary Syndromes.
Libby P, Pasterkamp G, Crea F, Jang IK
Circulation research 2019; (124(1)):150-160 doi:10.1161/CIRCRESAHA.118.311098.
PMID: 30605419 - 10
Significance of Intra-plaque Hemorrhage for the Development of High-Risk Vulnerable Plaque: Current Understanding from Basic to Clinical Points of View.
Sakamoto A, Suwa K, Kawakami R, et al.
International journal of molecular sciences 2023; (24(17)) doi:10.3390/ijms241713298.
PMID: 37686106 - 11
Risk Factors Favoring Plaque Erosion.
Hamana T, Shah P, Grogan A, et al.
Current atherosclerosis reports 2024; (27(1)):17 doi:10.1007/s11883-024-01262-y.
PMID: 39661076 - 12
Coronary Calcified Nodules: From Pathological Definitions to Intravascular Imaging- and Morphology-Guided PCI.
Lucki M, Iwańczyk S, Lucka E, et al.
International journal of molecular sciences 2026; (27(15)) doi:10.3390/ijms27156999.
PMID: 42589651 - 13
The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design.
Lambrakis K, French JK, Scott IA, et al.
American heart journal 2019; (208()):11-20 doi:10.1016/j.ahj.2018.09.016.
PMID: 30522086 - 14
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Guimarães PO, Leonardi S, Huang Z, et al.
American heart journal 2018; (196()):28-35 doi:10.1016/j.ahj.2017.10.007.
PMID: 29421012 - 15
Impact of Type 2 Myocardial Infarction (MI) on Hospital-Level MI Outcomes: Implications for Quality and Public Reporting.
Arora S, Strassle PD, Qamar A, et al.
Journal of the American Heart Association 2018; (7(7)) doi:10.1161/JAHA.118.008661.
PMID: 29581221 - 16
Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies.
Foà A, Canton L, Bodega F, et al.
Journal of cardiovascular medicine (Hagerstown, Md.) 2023; (24(Suppl 2)):e134-e146 doi:10.2459/JCM.0000000000001439.
PMID: 37186564
This page explains the biology of coronary thrombosis and heart attacks for educational purposes only; it does not constitute medical advice. Your cardiologist or other healthcare professional should interpret your diagnosis, troponin results, ejection fraction, and treatment plan.
Get notified when new evidence is published on coronary thrombosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.